Assessment of repolarization abnormalities in baseline electrocardiograms of patients with myocarditis

Background/aim: Myocarditis in the acute phase usually presents with sinus tachycardia but many other arrhythmias might be seen as well. In this study we aimed to investigate repolarization abnormalities in baseline ECG of patients with myocarditis for the first time. Materials and methods: Thirty patients diagnosed with myocarditis and 25 healthy age-matched controls were included. Two different cardiologists measured corrected QT (QTc), QT dispersion (QTd), QT peak (QTp), T wave peak to T wave end (TpTe), TpTe/QT ratio, and TpTe/QTc ratio in 12-lead ECG. Results: When compared with the control group, QTp (P: 0.021), QT (P: 0.003), TpTe (P < 0.001), TpTe/QTc ratio (P < 0.001), and TpTe/ QT ratio (P: 0.005) were significantly higher in patients with myocarditis. A comparison of receiver operating characteristic (ROC) curves was conducted using the Hanley and McNeil method. The area under the curve (AUC) of the electrocardiographic characteristics QT (AUC: 0.736; 95% CI [0.600 0.846]), QTP (AUC: 0.680; 95% CI [0.540 0.799]), and TpTe (AUC: 0.771; 95% CI [0.638 873]) and TpTe/QTc (AUC: 0.774; 95% CI [0.641 0.876]) and TpTe/QT (AUC: 0.726; 95% CI [0.589 0.838]) in myocarditis were not significantly different from each other but all of them were different from 0.5. Conclusion: Baseline ECGs of patients with myocarditis were associated with repolarization abnormalities. These novel findings may be one of the reasons underlying arrhythmic events in patients with myocarditis.

PDF

___

1. Caforio AL, Pankuweit S, Arbustini E, Basso C, Gimeno-Blanes J, Felix SB, Fu M, Heliö T, Heymans S, Jahns R et al. European Society of Cardiology Working Group on Myocardial and Pericardial Diseases. Current state of knowledge on aetiology, diagnosis, management, and therapy of myocarditis: a position statement of the European Society of Cardiology Working Group on Myocardial and Pericardial Diseases. Eur Heart J 2013; 34: 2636-2648.
2. Dec GW Jr, Palacios IF, Fallon JT, Aretz HT, Mills J, Lee DC, Johnson RA. Active myocarditis in the spectrum of acute dilated cardiomyopathies. Clinical features, histologic correlates, and clinical outcome. N Engl J Med 1985; 312: 885-890.
3. OConnell JB, Mason JW. Diagnosing and treating active myocarditis. West J Med 1989; 150: 431-435.
4. Olinde KD, OConnell JB. Inflammatory heart disease: pathogenesis, clinical manifestations, and treatment of myocarditis. Annu Rev Med 1994; 45: 481-490.
5. Baksi AJ, Kanaganayagam GS, Prasad SK. Arrhythmias in viral myocarditis and pericarditis. Card Electrophysiol Clin 2015; 7: 269-281.
6. Kılıçaslan F, Tokatlı A, Özdağ F, Uzun M, Uz O, Işılak Z, Yiğiner O, Yalçın M, Güney MS, Cebeci BS. Tp-e interval, Tp-e/QT ratio, and Tp e/QTc ratio are prolonged in patients with moderate and severe obstructive sleep apnea. Pacing Clin Electrophysiol 2012; 35: 966-972.
7. Demir C, Demir M. Evaluation of Tp-e interval and Tp-e/QT ratio in patients with chronic hepatitis B. Prague Med Rep 2013; 114: 239-245.
8. Lang RM, Bierig M, Devereux RB, Flachskampf FA, Foster E, Pellikka PA, Picard MH, Roman MJ, Seward J, Shanewise JS et al. Recommendations for chamber quantification: a report from the American Society of Echocardiographys Guidelines and Standards Committee and the Chamber Quantification Writing Group, developed in conjunction with the European Association of Echocardiography, a branch of the European Society of Cardiology. J Am Soc Echocardiog 2005; 18: 1440- 1463.
9. Cooper LT Jr. Myocarditis. N Engl J Med 2009; 360: 1526-1538.
10. Shultz JC, Hilliard AA, Cooper LT, Rihal CS. Diagnosis and treatment of viral myocarditis. Mayo Clin Proc 2009; 84: 1001- 1009.
11. Felker GM, Thompson RE, Hare JM, Hruban RH, Clemetson DE, Howard DL, Baughman KL, Kasper EK. Underlying causes and long-term survival in patients with initially unexplained cardiomyopathy. N Engl J Med 2000; 342: 1077-1084.
12. Drory Y, Turetz Y, Hiss Y, Lev B, Fisman EZ, Pines A, Kramer MR. Sudden unexpected death in persons less than 40 years of age. Am J Cardiol 1991; 68: 1388-1392.
13. Mason JW, OConnell JB, Herskowitz A, Rose NR, McManus BM, Billingham ME, Moon TE. A clinical trial of immunosuppressive therapy for myocarditis. The Myocarditis Treatment Trial Investigators. N Engl J Med 1995; 333: 269-275.
14. Chevalier P, Scridon A. Ventricular arrhythmias complicating acute myocarditis. E-journal of the ESC Council for Cardiology Practice 2011; 9: 26-26.
15. Klein RM, Vester EG, Brehm MU, Dees H, Picard F, Niederacher D, Beckmann MW, Strauer BE. Inflammation of the myocardium as an arrhythmia trigger. Z Kardiol 2000; 89: 24-35.
16. Sicouri S, Antzelevitch C.A. Subpopulation of cells with unique electrophysiological properties in the deep subepicardium of the canine ventricle. The M cell. Circ Res 1991; 68: 1729-1741.
17. Yontar OC, Karaagaç K, Tenekecioğlu E, Tütüncü A, Demir M, Melek M. Assessment of ventricular repolarization inhomogeneity in patients with mitral valve prolapse: value of T wave peak to end interval. Int J Clin Exp Med 2014; 7: 2173- 2178.
18. Ramamurthy S, Talwar KK, Goswami KC, Shrivastava S, Chopra P, Broor S, Malhotra A. Clinical profile of biopsy proven idiopathic myocarditis. Int J Cardiol 1993; 41: 225-232.
19. Amoozgar H, Ahmadipour M, Amirhakimi A. QT dispersion and T wave peak-to-end interval dispersion in children with Kawasaki disease. Int Cardiovasc Res J 2013; 7: 99-103.
20. Magrì D, Piccirillo G, Ricotta A, De Cecco CN, Mastromarino V, Serdoz A, Muscogiuri G, Gregori M, Casenghi M, Cauti FM et al. Spatial QT dispersion predicts nonsustained ventricular tachycardia and correlates with confined systodiastolic dysfunction in hypertrophic cardiomyopathy. Cardiology 2015; 131: 122-129.
21. Castro Hevia J, Antzelevitch C, Tornés Bárzaga F, Dorantes Sánchez M, Dorticós Balea F, Zayas Molina R, Quiñones Pérez MA, Fayad Rodríguez Y. Tpeak-Tend and TpeakTend dispersion as risk factors for ventricular tachycardia/ ventricular fibrillation in patients with the Brugada syndrome. J Am Coll Cardiol 2006; 47: 1828-1834.
22. Savelieva I, Yap YG, Yi G, Guo X, Camm AJ, Malik M. Comparative reproducibility of QT, QT peak, and T peakT end intervals and dispersion in normal subjects, patients with myocardial infarction and patients with hypertrophic cardiomyopathy. Pacing Clin Electrophysiol 1998; 21: 2376- 2381.
23. Watanabe N, Kobayashi Y, Tanno K, Miyoshi F, Asano T, Kawamura M, Mikami Y, Adachi T, Ryu S, Miyata A et al. Transmural dispersion of repolarization and ventricular tachyarrhythmias. J Electrocardiol 2004; 37: 191-200.
24. Wolk R, Stec S, Kulakowski P. Extrasystolic beats affect transmural electrical dispersion during programmed electrical stimulation. Eur J Clin Invest 2001; 31: 293-301.
25. Haarmark C, Hansen PR, Vedel-Larsen E, Pedersen SH, Graff C, Andersen MP, Toft E, Wang F, Struijk JJ, Kanters JK. The prognostic value of the Tpeak-Tend interval in patients undergoing primary percutaneous coronary intervention for ST-segment elevation myocardial infarction. J Electrocardiol 2009; 42: 555-560.
26. Viitasalo M, Oikarinen L, Swan H, Väänänen H, Glatter K, Laitinen PJ, Kontula K, Barron HV, Toivonen L, Scheinman MM. Ambulatory electrocardiographic evidence of transmural dispersion of repolarization in patients with long-QT syndrome types 1 and 2. Circulation 2002; 106: 2473-2478.
27. Sarubbi B, Pacileo G, Ducceschi V, Russo MG, Iacono C, Pisacane C, Iacono A, Calabrò R. Arrhythmogenic substrate in young patients with repaired tetralogy of Fallot: role of an abnormal ventricular repolarization. Int J Cardiol 1999; 72: 73- 82.
28. Letsas KP, Weber R, Astheimer K, Kalusche D, Arentz T. Tpeak-Tend interval and Tpeak-Tend/QT ratio as markers of ventricular tachycardia inducibility in subjects with Brugada ECG phenotype. Europace 2010; 12: 271-274.
29. Gupta P, Patel C, Patel H, Narayanaswamy S, Malhotra B, Green, JT, Yan GX. T(p-e)/QT ratio as an index of arrhythmogenesis. J Electrocardiol 2008; 41: 567-574.
30. Acar G, Yorgun H, Inci MF, Akkoyun M, Bakan B, Nacar AB, Dırnak I, Çetin GY, Bozoğlan O. Evaluation of Tp-e interval and Tp-e/QT ratio in patients with ankylosing spondylitis. Mod Rheumatol 2014; 24: 327-330.
31. Acar GR, Akkoyun M, Nacar AB, Dırnak I, Yıldırım Çetin G, Nur Yıldırım M, Zencir C, Karaman K, Çetin M, Sayarlıoğlu M. Evaluation of Tp-e interval and Tp-e/QT ratio in patients with rheumatoid arthritis. Turk Kardiyol Dern Ars 2014; 42: 29-34.
32. Demir M, Uyan U. Evaluation of Tp-e interval and Tp-e/QT ratio in patients with non-dipper hypertension. Clin Exp Hypertens 2014; 36: 285-288.
33. Alizade E, Avcı A, Fidan S, Tabakçı M, Bulut M, Zehir R, Şimşek Z, Evlice M, Arslantaş U, Çakır H et al. The effect of chronic anabolic-androgenic steroid use on Tp-E interval, Tp-E/Qt ratio, and Tp-E/Qtc ratio in male bodybuilders. Ann Noninvasive Electrocardiol 2015; 20: 592-600.